Search
Feed aggregator
Activists Declare Victory After Pushing J&J, Danaher to Lower Price of Tuberculosis Care
Activists Declare Victory After Pushing J&J, Danaher to Lower Price of Tuberculosis Care 11/8/2023
Opinion: Cell Therapy Cancer Treatments Are Coming. Now to Make Them More Accessible.
Opinion: Cell Therapy Cancer Treatments Are Coming. Now to Make Them More Accessible. 11/8/2023
Week in Review: Novo Nordisk Riding High, Novavax in the Black (For Now), Nektar Sues Lilly and More
Week in Review: Novo Nordisk Riding High, Novavax in the Black (For Now), Nektar Sues Lilly and More 8/11/2023
ALX Oncology Axes Two CD47 Programs on Disappointing Results
ALX Oncology Axes Two CD47 Programs on Disappointing Results 8/11/2023
Ultragenyx Sued by Henrietta Lacks’ Family in Second HeLa Cell Line Lawsuit
Ultragenyx Sued by Henrietta Lacks’ Family in Second HeLa Cell Line Lawsuit 8/11/2023
SEC Investigating Illumina’s Multi-Billion Dollar Merger with GRAIL
SEC Investigating Illumina’s Multi-Billion Dollar Merger with GRAIL 8/11/2023
SCOTUS Blocks $6B Purdue Pharma Bankruptcy Settlement
SCOTUS Blocks $6B Purdue Pharma Bankruptcy Settlement 8/11/2023
Regeneron’s High-Dose Eylea Allows for Longer Dosing Intervals in wAMD
Regeneron’s High-Dose Eylea Allows for Longer Dosing Intervals in wAMD 8/11/2023
Bayer expands global life science incubator network
Bayer AG today announced the global expansion of its life science incubator network, Bayer Co.Lab, to Shanghai, China, and Kobe, Japan.
This move establishes new sites for the Bayer Co.Lab program at the hotspots of innovation in China as well as in Japan.
Novartis Inks Potential $1.3B Contract with Korean Biotech for Small Molecule
Novartis Inks Potential $1.3B Contract with Korean Biotech for Small Molecule 11/7/2023
Ventyx Nixes Psoriasis Candidate Despite Positive Results, Stock Nosedives 75%
Ventyx Nixes Psoriasis Candidate Despite Positive Results, Stock Nosedives 75% 11/7/2023
Vertex Q3 Revenue Falls Short, Looks to Potential CRISPR Therapy Approval
Vertex Q3 Revenue Falls Short, Looks to Potential CRISPR Therapy Approval 11/7/2023
HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations
HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations 11/7/2023
BioSpace Announces 2024 Best Places to Work in Biopharma
BioSpace Announces 2024 Best Places to Work in Biopharma 11/7/2023
What Makes a Company a Great Place to Work? Moderna and Tessera Share Their Insights
What Makes a Company a Great Place to Work? Moderna and Tessera Share Their Insights 11/7/2023
Gilead, Arcus Anti-TIGIT Combo Gets Phase II Win in Upper GI Cancers
Gilead, Arcus Anti-TIGIT Combo Gets Phase II Win in Upper GI Cancers 11/7/2023
Cargo Therapeutics Plans $315M IPO, Targets Cell Therapies for Cancer
Cargo Therapeutics Plans $315M IPO, Targets Cell Therapies for Cancer 11/7/2023
First in human trial of new drug raises hopes for patients with relapsed blood cancer
A new targeted drug, studied by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), may offer a new treatment option for patients with blood cancers, including chronic lymphocytic leukemia (CLL) and Non-Hodgkin lymphoma (NHL) whose disease has stopped responding to standard treatments.
FDA Advisory Panel Strongly Backs Perrigo’s OTC Birth Control Pill
FDA Advisory Panel Strongly Backs Perrigo’s OTC Birth Control Pill 5/11/2023
FDA Rejects ImmunityBio's Bladder Cancer Therapy, Sends Stock Tumbling
FDA Rejects ImmunityBio's Bladder Cancer Therapy, Sends Stock Tumbling 5/11/2023
World Pharma News
- The risk of cardiovascular disease can be reduced by eating more oily fish
- New technique efficiently offers insight into gene regulation
- Pfizer announces topline Phase 2b results of oral GLP-1R agonist, danuglipron, in adults with obesity
- A patch of protection against Zika virus
- Scientists uncover how fermented-food bacteria can guard against depression, anxiety